期刊文献+

SUMO融合系统表达人白细胞介素17及其活性的研究 被引量:3

Utilization of SUMO expressing vector to express human interleukin-17 and studying of its bioactivity
下载PDF
导出
摘要 目的:克隆、表达和纯化人白细胞介素17(hIL-17),并对其生物学活性进行研究。方法:采用RT-PCR的方法从活化的人T细胞中克隆获得hIL-17cDNA。构建了含羟胺切割位点的重组载体pHisSUMO-hIL-17,导入宿主菌Rosetta中,经IPTG诱导后得到表达。用Ni-NTA琼脂糖颗粒层析纯化融合蛋白,经羟胺切割,复性,通过Western blot实验进行确认,并从核酸水平和蛋白水平鉴定其活性。结果:克隆表达出了hIL-17,利用Ni-NTA琼脂糖颗粒层析纯化得到的纯品蛋白经体外活性实验表明,该蛋白具有刺激3T3-L1细胞和HeLa细胞分泌IL-6、IL-8、G-CSF的作用。结论:制备了具有生物学活性的成熟hIL-17蛋白,为进一步研究该分子在疾病中的作用奠定了基础。 Objective:The aim of the paper is to clone,express,purify and characterize human interleukin-17(hIL-17).Methods:The hIL-17 cDNA was cloned from activated human T cells by RT-PCR.Recombinant vector pHisSUMO-hIL-17 with a hydroxylamine cleavage site was constructed and transformed into the host bacteria Rosetta.The fusion protein was expressed by IPTG induction.Ni-NTA affinity chromatography purification column was utilized to purify His-SUMO-hIL-17 fusion protein.The recombinant protein was confirmed by Western blot.Cytokines induction by the hIL-17 were analyzed at both RNA and protein levels.Results:The IL-17 was cloned from human T cells,expressed in prokaryotic cells and purified by Ni-NTA affinity column.The hIL-17 could stimulate 3T3-L1 and Hela cell to express IL-6,IL-8,G-CSF at both RNA and protein levels.Conclusion:The hIL-17 is cloned and expressed in prokaryotic cells.The purified and bioactive hIL-17 protein was obtained for further studies.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2010年第7期595-600,605,共7页 Chinese Journal of Immunology
基金 哈尔滨市科技创新人才发展计划(2006RFXXS002) 东北农业大学创新团队发展计划资助
关键词 hIL-17 表达 纯化 活性试验 Human interleukin-17 Expression Purification Bioactivity
  • 相关文献

参考文献16

  • 1Yao Z, Fanslow W C, Seldin M F et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor[ J]. Immunity, 1995 ;3(6) :811-821.
  • 2Yao Z, Painter S L, Fanslow W C et al. Human IL-17: a novel cytokine derived from T cells [ J ]. J Immunol, 1995 ; 155 ( 12 ) : 5483 -5486.
  • 3Moseley T A, Haudenschild D R, Rose Let al. Interleukin-17 family and IL-17 receptors[J]. Cytokine Growth Factor Rev, 2003; 14(2) : 155-174.
  • 4Laan M, Cui Z H, Hoeshino Het al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the air ways[J] .J Immunol, 1999; 162 (4) : 2347-2352.
  • 5Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy [ J ]. Arthritis Rheum, 2003 ; 48 (3) : 594-601.
  • 6Marblestone J G, Edavettal S C, Lim Yet al. Comparison of SUMO fusion .technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO[ J ]. Protein Science, 2006; 15 : 182-189.
  • 7Bomstein P, Balian G. Cleavage at Asn-Gly bonds with hydroxylamine[ J]. Methods Enzymol, 1997 ; 47 : 132-145.
  • 8Fossiez F, Djossou O, Chomarat P et al. T cell interleukin-17 includes stromal ceils to produce proinflammatory and hematopoietic cytokines[ J]. J Exp Med, 1996; 183:259-260.
  • 9Broxmeyer H E. Is interleukin-17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules [ J ]. J Exp Med, 1996; 183 : 2411-2415.
  • 10Schwandner R, Yamaguchi K, Cao Z et al. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interlcukin-17 signal transduction[ J]. J Exp, 2000,191 (7): 1233-1240.

二级参考文献19

  • 1李青,吴雄文,熊敏,翁秀芳,卢小玲,梁智辉,龚非力.BirA酶基因表达载体的构建、原核表达及表达产物的活性鉴定[J].细胞与分子免疫学杂志,2005,21(5):557-560. 被引量:9
  • 2黄欣 赵忠良 等.白细胞介素17(IL-17)的克隆在大肠杆菌中的表达[J].中国肿瘤生物防治杂志,1998,5(1):13-13.
  • 3Barker DF, Campbell AM. The birA gene of Escherichia coli encodes abiotin holoenzyme synthetase[J]. J Mol Biol, 1981, 146(4): 451-467.
  • 4Barker DF, Campbell AM. Genetic and biochemical characterization ofthe birA gene and its product: evidence for a direct role of biotinholoenzyme synthetase in repression of the biotin operon in Escherichiacoli[J]. J Mol Biol, 1981, 146(4): 469-492.
  • 5Gillespie G, Mutis T, Schrama E, et al. HLA class I-minorhistocompatibility antigen tetramers select cytotoxic T cells with highavidity to the natural ligand[J]. Hematol J, 2000, 1(6): 403-410.
  • 6Schatz PJ. Use of peptide libraries to map the substrate specificityof a peptide-modifying enzyme: a 13 residue consensus peptide specifiesbiotinylation in Escherichia coli[J]. Biotechnology (NY), 1993, 11(10):1138-1143.
  • 7Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis ofantigen-specific T lymphocytes[J]. Science, 1996, 274(5284): 94-96.
  • 8Ladasky JJ, Shum BP, Canavez F, et al. Residue 3 ofbeta2-microglobulin affects binding of class I MHC molecules by the W6/32antibody[J]. Immunogenetics, 1999, 49(4): 312-320.
  • 9O'callaghan CA, Byford MF, Wyer JR, et al. BirA enzyme: production andapplication in the study of membrane receptor-ligand interactions bysite-specific biotinylation[J]. Anal Biochem, 1999, 266(1): 9-15.
  • 10Rouvier E,Luciani MF,Mttei MG,et al.CTLA-8,cloned from an activated T cell,bearing AU-Rich messenger RNA instability sequence,and homlogous to a Herpesvirus Saimiri gene[J].J Immunol,1993,150(12):5445-5456.

共引文献16

同被引文献32

  • 1陈晓穗,汪保安,周丽君,王欲晓,曲佳,张达矜,王琰.热点突变法提高人源抗TNF-α抗体的亲和力[J].中华微生物学和免疫学杂志,2004,24(8):644-648. 被引量:2
  • 2Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cy- tokine receptor [J]. hnmunity, 1995, 3 (6): 811-821.
  • 3Laan M, Cui ZH, Hoeshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the air ways [J]. J Immunol, 1999, 162 (4): 2347-2352.
  • 4Miossec P. lnterleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy [J]. Arthritis Rheum, 2003, 48 (3): 594-601.
  • 5Antonysamy MA, Fanslow WC, Fu F, et al. Evidence for a role of i1-17 in aJloimmunity: a novel IL-17 antagonist pro- motes heart graft survival [J]. Transplant Proc, 1999, 31 (1/2): 93.
  • 6van Kooten C, Boonstra JG, Paape ME, et al. INTER- LEUKIN-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection[J]. J Am Soc Nephrol, 1998, 9 (8): 1526-1534.
  • 7Cervino C, Knopp D, Weller MG, et al. Novel aflatoxin deri- tatives and protein conjugate [J]. Molecules, 2007, 12 (3): 641-653.
  • 8Zhou YX, Wu J, Yu W, et al. Preparation for aflatoxin Bl-cationized bovine serum albumin based on Man- nich-type reaction [J]. J Immunol Methods, 2007, 328 (1/2): 79-88.
  • 9Beatty JD, Beatty GB, Vlahos WG. Measurement of mono- clonal antibody affinity by non-competitive enzyme im- munoassay [J]. J Immunol Methods, 1987, 100 (1/2): 173-179.
  • 10Witowski J, Pawlaczyk K, Brebarowicz A, et al. IL-17 stim- ulates intraperitoneal neutrophil infiltration through the re-lease of Gro alpha chemokine from mesothelial cells [J]. J Immunol, 2000, 165 (10): 5814-5821.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部